PMDA drug package insert
レナデックス錠2mg
PMDA Prescription drug · ブリストル・マイヤーズ スクイブ株式会社 · package insert Mar 31, 2026
Key facts
| Brand names | レナデックス錠2mg, レナデックス錠4mg |
|---|---|
| Nonproprietary names | デキサメタゾン |
| Companies | 製造販売元／ブリストル・マイヤーズ スクイブ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 副腎皮質ホルモン製剤 |
| Therapeutic category codes | 872454 |
| YJ codes | 24540A1F1026, 2454002F2023 |
| Approval numbers | 30300AMX00045000, 22200AMX00378000 |
| Package insert edition | 第7版 |
| Package insert date | Mar 31, 2026 |
| PMDA document key | 670605_2454002F2023_2 |
| PMDA company code | 670605 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: